Grace Therapeutics, Inc. Payments of Financing Costs
Grace Therapeutics, Inc. (GRCE) reported Payments of Financing Costs of $143.00 thousand for the 9-month period ending 2020-12-31, per its 10-Q filed 2021-02-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2021-02-09
- Grace Therapeutics, Inc. payments of financing costs for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- Grace Therapeutics, Inc. payments of financing costs for the quarter ending 2020-09-30 was $1.00K, a 97.22% decline year-over-year.
- Grace Therapeutics, Inc. payments of financing costs for the quarter ending 2019-12-31 was $31.00K.
- Grace Therapeutics, Inc. payments of financing costs for the quarter ending 2019-09-30 was $36.00K.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month |
|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-09 | $1.00K derived: sum of 2 quarters · filed 2021-02-09 | $143.00K 10-Q · filed 2021-02-09 |
| 2020-09-30 | $1.00K 10-Q · filed 2020-11-16 | $143.00K 10-Q · filed 2020-11-16 | |
| 2019-12-31 | $31.00K 10-Q · filed 2021-02-09 | $67.00K derived: sum of 2 quarters · filed 2021-02-09 | $67.00K 10-Q · filed 2021-02-09 |
| 2019-09-30 | $36.00K 10-Q · filed 2020-11-16 | $36.00K 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |